Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Marketing
Closing the loop on pharmaceutical marketing
By Corbett Accel Healthcare Group. Pharmaceutical companies continue to switch their sales forces from paper to Tablet PCs, with over 50% of all sales representatives in the US having already made the switch.
Understanding new influences acting on healthcare practitioners: Gaining a 360-degree view of customers
Increasingly, prescribing decisions are influenced by new and dynamic factors that did not exist only a few years ago: peer-to-peer electronic media, health plan-mandated prescribing algorithms, and patient-led treatment strategies.
New Jersey’s Edison Innovation Fund supports growth of pharmaceutical and other life sciences and technology businesses
When Axcan Pharma was choosing whether to expand its U.S. headquarters in Alabama or establish a facility farther north, a Business Employment Incentive Program (BEIP) offered by the State of New Jersey worth an estimated $580,000 over 10 years was a material factor in the specialty pharmaceutical company's decision to locate in the Garden State.
Choosing a hi-tech venue
Eric Opron of Walt Disney explains what businesses should expect from their communications technology when planning their next off-site event.
Understanding the new prescribing influences
Tom Haskell and John Moran of IMS’ Innovation Lab discuss how to evaluate new factors driving prescribing decisions.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.